Report | India Deal Review Q2 2025 - Leaderboard

Japan's Astellas Pharma agrees to acquire IVERIC Bio for $5.9b

Japan's Astellas Pharma agrees to acquire IVERIC Bio for $5.9b

Photo: Pixabay

Baranjot Kaur, Rocky Swift

01 May, 2023

astellas pharma

Printed by Unregistered user on Tue, 26 Aug 2025 17:28:36 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Japan's Astellas Pharma maintains full-year profit forecast amid overseas M&A

Japan's Astellas Pharma buys US biotech Xyphos for $665m

Read more from Rest of Asia

Abu Dhabi’s Lunate to take minority stake in hedge fund Brevan Howard

Mercedes-Benz pension trust offloads Nissan stake for $325m: report